Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/15/2003WO2002040654A3 A human serpin secreted from lymphoid cells lsi-01
05/15/2003WO2002040480A3 Crf receptor antagonists and methods relating thereto
05/15/2003WO2002040016A8 Association of calpain inhibitors and reactive oxygen species trapping agents
05/15/2003WO2002038208A3 Device and method for the cessation of smoking
05/15/2003WO2002038181A3 Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect
05/15/2003WO2002030462A9 Hedgehog antagonists, methods and uses related thereto
05/15/2003WO2002030357A3 Compounds and methods for modulating ccr4 function
05/15/2003WO2002026717A8 Hydroxy acid integrin antagonists
05/15/2003WO2002018407A9 Antisense oligonucleotides against vanilloid receptor 1
05/15/2003WO2002004423A9 Thrombin inhibitors comprising an aminoisoquinoline group
05/15/2003WO2002000629A9 Iminopyrimidine nmda nr2b receptor antagonists
05/15/2003WO2002000611A8 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists
05/15/2003WO2001080832A3 Administration of a thiol-based chemoprotectant compound
05/15/2003WO2001079173A3 Enamine derivatives as cell adhesion molecules
05/15/2003WO2001071309A3 Methods and reagents for regulation of cellular responses in biological systems
05/15/2003WO2001022791A8 Controlled release compositions comprising nimesulide
05/15/2003US20030093115 Hemostasis pad and method
05/15/2003US20030093114 Method for effecting hemostasis
05/15/2003US20030093075 For effecting hemostasis at a puncture wound with an indwelling tubular element extending therethrough
05/15/2003US20030092919 Method for the preparation of citalopram
05/15/2003US20030092917 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as portein kinase inhibitors
05/15/2003US20030092916 Process for the preparation of thiazolidinedione derivatives
05/15/2003US20030092911 Hydrolysis in presence of phase transfer agents; antiallergens
05/15/2003US20030092908 Autoimmune diseases; rheumatic diseases; multiple sclerosis; inflammatory bowel disease; immunosuppressants
05/15/2003US20030092782 Adsorber of phosphorus
05/15/2003US20030092775 Process for the preparation of meso-zeaxanthin
05/15/2003US20030092774 In situ administering; iontophoresis; for eyes, joints
05/15/2003US20030092771 Inhibitors of transcription factor NF-kappaB
05/15/2003US20030092770 Synergistic mixture of antidepressant and alpha-amino-3-hydrocy-5-methylisooxazole-4-propionic acid receptor propentiator
05/15/2003US20030092766 Methods and compositions for modulating alpha adrenergic receptor activity
05/15/2003US20030092765 Irritable bowel disorders; infections of intestine
05/15/2003US20030092764 Oxidation resistance
05/15/2003US20030092763 Method for induction of L-selectin shedding
05/15/2003US20030092762 Anti-inflammatory nitro and thia-fatty acids
05/15/2003US20030092761 Method for the preparation of citalopram
05/15/2003US20030092760 Therapeutic agent for renal failure
05/15/2003US20030092759 Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder
05/15/2003US20030092758 Use of a RAR-gamma-specific agonist ligand for increasing the rate of apoptosis
05/15/2003US20030092757 Administering endothelin receptor anatgonist; anticancer agent
05/15/2003US20030092756 Antiproliferative agents
05/15/2003US20030092755 Novel prodrugs for antimicrobial amidines
05/15/2003US20030092754 External preparation for skin diseases containing nitroimidazole
05/15/2003US20030092753 Methods for the treatment and prevention of neurodegenerative conditions
05/15/2003US20030092752 Medical diagnosis; complexing with label
05/15/2003US20030092751 3-glyoxlylamideindoles for treating cancer
05/15/2003US20030092750 Insulin activation
05/15/2003US20030092749 Kinase inhibitors; antiinflammatory agents; osteoporosis; anticancer agents
05/15/2003US20030092748 Benzenesulfonamide derivatives and their use as MEK inhibitors
05/15/2003US20030092747 Secretase inhibitor
05/15/2003US20030092745 Combination therapy
05/15/2003US20030092744 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
05/15/2003US20030092743 Viricides; aids therapy
05/15/2003US20030092741 Novel alpha adrenergic agents
05/15/2003US20030092738 Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity
05/15/2003US20030092737 Combination of active ingredients for the treatment of senile dementia of the Alzheimer type
05/15/2003US20030092736 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
05/15/2003US20030092735 Use of substance P antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of NK-1 receptor antagonists for the treatment of chronic fatigue syndrome
05/15/2003US20030092734 Therapy for sleep disorders
05/15/2003US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases
05/15/2003US20030092730 Glutamate receptor antagonist
05/15/2003US20030092729 Anticancer agents; modulating glycoprotein
05/15/2003US20030092728 Antagonists of MCP-1 function and methods of use thereof
05/15/2003US20030092727 Hydroxamic and carboxylic acid derivatives
05/15/2003US20030092725 Control dosage of vasodilator; sexual disorders
05/15/2003US20030092724 Multilayer dosage form
05/15/2003US20030092721 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092720 Drug efflux pump inhibitor
05/15/2003US20030092719 Methods and kits for treating depression or preventing deterioration of cognitive function
05/15/2003US20030092718 4-amino-2-(2-pyridyl)pyrimidines as microbicidal active substances
05/15/2003US20030092717 Inhibitors of p38 kinase
05/15/2003US20030092716 Antihypoxic agents
05/15/2003US20030092715 Aryl and biaryl compounds having MCH modulatory activity
05/15/2003US20030092714 Heterocyclic inhibitors of ERK2 and uses thereof
05/15/2003US20030092713 Antiinflammatory agents; antiallergens; psychological disorders
05/15/2003US20030092712 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092711 Contraceptives; hormone replacement therapy
05/15/2003US20030092708 Anticholesterol agents; cardiovascular disorders; antilipemic agents
05/15/2003US20030092707 Treatment of breast cancer
05/15/2003US20030092706 Mixtures of phosphodiesterase inhibitor and antiarthritic agents; bioavailability, side effect reduction
05/15/2003US20030092705 Reverse malaria drug resistance
05/15/2003US20030092704 Novel arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
05/15/2003US20030092703 Caspase inhibitors and uses thereof
05/15/2003US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases
05/15/2003US20030092701 Syngergistic mixture of opiod and dopamine receptor antagonist
05/15/2003US20030092698 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa
05/15/2003US20030092697 Antidiabetic, antilipemic agents; cardiovascular disorders; anticancer agents
05/15/2003US20030092696 7-Alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors
05/15/2003US20030092695 Hormone inhibitors; therapy for sexual disorders
05/15/2003US20030092693 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor
05/15/2003US20030092692 Alzheimer's and parkinson's disease
05/15/2003US20030092691 Pharmaceutical composition based on micronized progesterone, method for the preparation thereof and uses thereof
05/15/2003US20030092690 Administering by inhalation
05/15/2003US20030092688 Non-combustible water-dispersible vitamin compositions
05/15/2003US20030092687 5,6-Trans-2-alkylvitamin d derivatives
05/15/2003US20030092686 Calibrating therapy dosage
05/15/2003US20030092683 Use of tetracyclines as neuro-protective agents and for the treatment of parkinson's disease and related disorders
05/15/2003US20030092682 Use of doxycycline for treatment of certain skin and mouth ailments
05/15/2003US20030092681 Anticancer agents
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003US20030092677 Glutamate receptor antagonists
1 ... 5467 5468 5469 5470 5471 5472 5473 5474 5475 5476 5477 5478 5479 5480 5481 5482 5483 5484 5485 5486 5487 ... 7860